J&J's Christine Poon accepts additional roles

Christine Poon, worldwide chairman, medicines and nutritionals, and member of the executive committee of Johnson & Johnson was appointed as vice chairman of the company.
With this appointment, Poon becomes a member of the office of the chairman, joining chairman and chief executive, William Weldon and vice chairman and chief financial officer, Robert Darretta.
In addition, the nominating & corporate governance committee of the board of directors has nominated Poon for election to the board at the annual meeting of shareholders in April.
Poon will continue to have management responsibility for all pharmaceutical, consumer pharmaceutical, and nutritional businesses and report directly to Weldon.
"Since her arrival, our pharmaceutical business has become one of the fastest growing in the industry," Weldon said. "Simultaneously, Chris has championed our pharmaceutical R&D organization as it develops and supports a robust pipeline of new medicines. She has exhibited strong leadership and personal involvement in building a skilled and diverse workforce. I look forward to her deeper contributions in strategic planning and talent development."
Poon's achievements in pharmaceuticals earned her the honor of being named the 2004 Healthcare Businesswomen's Association (HBA) Woman of the Year.
She is a member of the advisory board of the HBA and is on the board of directors of the Fox Chase Cancer Center in Philadelphia, Pa.
You must be a registered member of MMM to post a comment.

Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.